Penserra Capital Management LLC Insmed Inc Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$25.89 - $33.45 $68,220 - $88,140	-2,635 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$22.46 - $29.47 $336 - $442	15 Added 0.57%	2,635 $72,000
Q2 2021 Aug 12, 2021	BUY	$24.17 - $36.01 $7,009 - $10,442	290 Added 12.45%	2,620 $74,000
Q1 2021 May 13, 2021	SELL	$32.28 - $44.3 $161 - $221	-5 Reduced 0.21%	2,330 $79,000
Q4 2020 Feb 12, 2021	BUY	$31.45 - $40.54 $46,200 - $59,553	1,469 Added 169.63%	2,335 $77,000
Q3 2020 Nov 13, 2020	BUY	$26.0 - $34.5 $22,516 - $29,877	866 New	866 $27,000

490

188M

3.04M

3.15M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.7B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.